• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cell-of-origin in diffuse large B-cell lymphoma: findings from the UK's population-based Haematological Malignancy Research Network.

作者信息

Painter Daniel, Barrans Sharon, Lacy Stuart, Smith Alexandra, Crouch Simon, Westhead David, Sha Chulin, Patmore Russell, Tooze Reuben, Burton Cathy, Roman Eve

机构信息

Epidemiology & Cancer Statistics Group, Department of Health Sciences, University of York, York, UK.

Haematological Malignancy Diagnostic Service, St James's University Hospital, Leeds, UK.

出版信息

Br J Haematol. 2019 May;185(4):781-784. doi: 10.1111/bjh.15619. Epub 2018 Nov 8.

DOI:10.1111/bjh.15619
PMID:30408148
Abstract
摘要

相似文献

1
Cell-of-origin in diffuse large B-cell lymphoma: findings from the UK's population-based Haematological Malignancy Research Network.弥漫性大B细胞淋巴瘤的起源细胞：来自英国基于人群的血液恶性肿瘤研究网络的发现。
Br J Haematol. 2019 May;185(4):781-784. doi: 10.1111/bjh.15619. Epub 2018 Nov 8.
2
Clinical Significance of , C-, and Genetic Abnormalities, Epstein-Barr Virus Infection, CD5 Protein Expression, Germinal Center B Cell/Non-Germinal Center B-Cell Subtypes, Co-expression of MYC/BCL2 Proteins and Co-expression of MYC/BCL2/BCL6 Proteins in Diffuse Large B-Cell Lymphoma: A Clinical and Pathological Correlation Study of 120 Patients.弥漫性大 B 细胞淋巴瘤中 、 、 和遗传异常、Epstein-Barr 病毒感染、CD5 蛋白表达、生发中心 B 细胞/非生发中心 B 细胞亚型、MYC/BCL2 蛋白共表达和 MYC/BCL2/BCL6 蛋白共表达的临床意义：120 例患者的临床与病理相关性研究。
Int J Med Sci. 2019 Apr 20;16(4):556-566. doi: 10.7150/ijms.27610. eCollection 2019.
3
Prognostic Significance of Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium.弥漫性大 B 细胞淋巴瘤中重排和易位伙伴的预后意义：Lunenburg 淋巴瘤生物标志物联盟的研究。
J Clin Oncol. 2019 Dec 10;37(35):3359-3368. doi: 10.1200/JCO.19.00743. Epub 2019 Sep 9.
4
Outcome of elderly patients with diffuse large B-cell lymphoma treated with R-CHOP: results from the UK NCRI R-CHOP14v21 trial with combined analysis of molecular characteristics with the DSHNHL RICOVER-60 trial.接受R-CHOP治疗的老年弥漫性大B细胞淋巴瘤患者的结局：来自英国国家癌症研究所R-CHOP14v21试验以及与DSHNHL RICOVER-60试验分子特征联合分析的结果。
Ann Oncol. 2017 Jul 1;28(7):1540-1546. doi: 10.1093/annonc/mdx128.
5
Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma.MYC和BCL6同时重排及表达对初发弥漫性大B细胞淋巴瘤的预后影响
Oncotarget. 2016 Jan 19;7(3):2401-16. doi: 10.18632/oncotarget.6262.
6
MYC single-hit large B-cell lymphoma: clinicopathologic difference from MYC-negative large B-cell lymphoma and MYC double-hit/triple-hit lymphoma.MYC单打击大B细胞淋巴瘤：与MYC阴性大B细胞淋巴瘤及MYC双打击/三打击淋巴瘤的临床病理差异
Hum Pathol. 2021 Jul;113:9-19. doi: 10.1016/j.humpath.2021.03.006. Epub 2021 Mar 23.
7
High Incidence and Clinical Significance of MYC Rearrangements in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.原发性皮肤弥漫性大 B 细胞淋巴瘤，腿型中 MYC 重排的高发生率和临床意义。
Am J Surg Pathol. 2018 Nov;42(11):1488-1494. doi: 10.1097/PAS.0000000000001132.
8
P53 expression correlates with poorer survival and augments the negative prognostic effect of MYC rearrangement, expression or concurrent MYC/BCL2 expression in diffuse large B-cell lymphoma.P53表达与弥漫性大B细胞淋巴瘤较差的生存率相关，并增强了MYC重排、表达或同时存在的MYC/BCL2表达的负面预后影响。
Mod Pathol. 2017 Feb;30(2):194-203. doi: 10.1038/modpathol.2016.178. Epub 2016 Oct 14.
9
Inferior survival in high-grade B-cell lymphoma with and and/or rearrangements is not associated with gene rearrangements.伴有 和/或 重排的高级别 B 细胞淋巴瘤患者的生存情况较差，但与 基因重排无关。
Haematologica. 2018 Nov;103(11):1899-1907. doi: 10.3324/haematol.2018.190157. Epub 2018 Jun 14.
10
MYC gene rearrangement in diffuse large B-cell lymphoma does not confer a worse prognosis following dose-adjusted EPOCH-R.弥漫性大B细胞淋巴瘤中的MYC基因重排在剂量调整的EPOCH-R治疗后并不会导致更差的预后。
Leuk Lymphoma. 2018 Feb;59(2):505-508. doi: 10.1080/10428194.2017.1339882. Epub 2017 Jun 22.

引用本文的文献

1
Prognostic marker Musashi-2 modulates DNA damage response and radioresistance in diffuse large B-cell lymphoma.预后标志物Musashi-2调节弥漫性大B细胞淋巴瘤中的DNA损伤反应和放射抗性。
Front Cell Dev Biol. 2025 Aug 6;13:1575483. doi: 10.3389/fcell.2025.1575483. eCollection 2025.
2
Genetic subtyping by Whole Exome Sequencing across Diffuse Large B Cell Lymphoma and Plasmablastic Lymphoma.通过全外显子测序对弥漫性大B细胞淋巴瘤和浆母细胞淋巴瘤进行基因分型。
PLoS One. 2025 Mar 11;20(3):e0318689. doi: 10.1371/journal.pone.0318689. eCollection 2025.
3
Reliable machine learning models in genomic medicine using conformal prediction.
使用共形预测的基因组医学中的可靠机器学习模型。
Front Bioinform. 2025 Feb 24;5:1507448. doi: 10.3389/fbinf.2025.1507448. eCollection 2025.
4
Revealing the heterogeneity of treatment resistance in less-defined subtype diffuse large B cell lymphoma patients by integrating programmed cell death patterns and liquid biopsy.通过整合程序性细胞死亡模式和液体活检揭示定义较不明确的亚型弥漫性大B细胞淋巴瘤患者治疗耐药的异质性。
Clin Transl Med. 2025 Jan;15(1):e70150. doi: 10.1002/ctm2.70150.
5
Clinical scoring systems, molecular subtypes and baseline [F]FDG PET/CT image analysis for prognosis of diffuse large B-cell lymphoma.用于弥漫性大B细胞淋巴瘤预后评估的临床评分系统、分子亚型及基线[F]FDG PET/CT图像分析
Cancer Imaging. 2024 Dec 18;24(1):168. doi: 10.1186/s40644-024-00810-8.
6
Molecular Subtypes and the Role of TP53 in Diffuse Large B-Cell Lymphoma and Richter Syndrome.分子亚型及TP53在弥漫性大B细胞淋巴瘤和里氏综合征中的作用
Cancers (Basel). 2024 Jun 7;16(12):2170. doi: 10.3390/cancers16122170.
7
Comprehensive analysis of the prognostic implication and immune infiltration of CISD2 in diffuse large B-cell lymphoma.全面分析 CISD2 在弥漫性大 B 细胞淋巴瘤中的预后意义和免疫浸润。
Front Immunol. 2023 Dec 12;14:1277695. doi: 10.3389/fimmu.2023.1277695. eCollection 2023.
8
Comparison of MHG and DZsig reveals shared biology and a core overlap group with inferior prognosis in DLBCL.MHG与DZsig的比较揭示了弥漫性大B细胞淋巴瘤（DLBCL）中共同的生物学特性以及一个预后较差的核心重叠组。
Blood Adv. 2023 Oct 24;7(20):6156-6162. doi: 10.1182/bloodadvances.2023010673.
9
Identification of related to Activated Memory CD4 T Cells Infiltration by Gene Co-expression Network and Construction of a Risk Prediction Module in Diffuse Large B-Cell Lymphoma.通过基因共表达网络鉴定与活化记忆性CD4 T细胞浸润相关的基因并构建弥漫性大B细胞淋巴瘤风险预测模型
Front Genet. 2022 May 30;13:849422. doi: 10.3389/fgene.2022.849422. eCollection 2022.
10
CD24 is a surrogate for 'immune-cold' phenotype in aggressive large B-cell lymphoma.CD24是侵袭性大B细胞淋巴瘤中“免疫冷”表型的替代标志物。
J Pathol Clin Res. 2022 Jul;8(4):340-354. doi: 10.1002/cjp2.266. Epub 2022 Mar 14.